Atara Bio to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that...
Feb 29, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 29, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Natural Health Trends Corp. (“Natural Health Trends” or the “Company”)(NASDAQ:NHTC) and certain of its officers. The...
Chiasma Joins Patient Organizations Worldwide in Support of Rare Disease Day
Feb 29, 2016 13:00 pm UTC| Business
NEWTON, Mass., Feb. 29, 2016 -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical company, today announced its support for Rare Disease Day 2016. In honor of Rare Disease Day, President and Chief Executive...
TubeMogul Program to Provide Automatic Refunds for Non-Human Traffic
Feb 29, 2016 13:00 pm UTC| Business
EMERYVILLE, Calif., Feb. 29, 2016 -- Today, TubeMogul (NASDAQ:TUBE), an enterprise software company for brand advertising, announced the launch of its Non-Human Traffic Credit Program. Available to platform clients that...
Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 29, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
TOMI™ to Present at the 28th Annual ROTH Conference
Feb 29, 2016 13:00 pm UTC| Business
BEVERLY HILLS, Calif., Feb. 29, 2016 -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, announced it will present at the 28th Annual ROTH...
Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare Conference
Feb 29, 2016 13:00 pm UTC| Business
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 29, 2016 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing and commercializing...